
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Companys research and development activities are focused on creating novel therapies for cardiovascular, metabolic and related diseases. CiVis innovative pipeline includes CiVi007, a long-acting PCSK9 third-generation Locked Nucleic Acid antisense molecule being developed for the treatment of hypercholesterolemia and the prevention of cardiovascular disease. In addition, the Company currently has other clinical stage development program activity aimed at treating severe liver diseases
Biotechnology,cardiovascular diseases,metabolic diseases,and clinical trials
Civi biopharma, inc operates in the Biotechnology research industry.
Civi biopharma, inc's revenue is 11m - 100m
Civi biopharma, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.